[Etiology of schizophrenia: neurochemical aspects].
de las Cuevas Castresana
C
C
Cátedra de Psiquiatría, Facultad de Medicina, Universidad de La Laguna, Santa Cruz de Tenerife.
González de Rivera
J L
JL
D014150:Antipsychotic Agents / Q000494:pharmacology*; D018492:Dopamine Antagonists; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid / Q000378:metabolism*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine; D006897:Hydroxyindoleacetic Acid; D008995:Monoamine Oxidase; D006719:Homovanillic Acid